The effect of HExA exoskeleton robot on stroke patients

Recruitment & Eligibility

Status: Pending

Sex: All

Target Recruitment: 20

Inclusion Criteria

Ischemic or hemorrhagic stroke patients in subacute phase(less than 3 month)
Involvement of one side of the body(hemiplegia)
Age 18-85 years
Patients have the ability to walk without the help of others (with or without a cane, etc.) (low to moderate disorder)
The patient should be able to understand the therapist's instructions, which will be diagnosed using the Mini-mental state examination (MMSE) (MMSE score=24)

Exclusion Criteria

The patient be in flaccid phase that can not walk even with the help of therapist or use of assistive device such as cane
Stroke due to tumor or infection
Significant musculoskeletal or neurological impairment
Uncontrolled cardiovascular or respiratory impairments
Involvement of two sides of the body or quadriplegia
Pregnancy
A patient with Pusher syndrome will not be included in the study
The patient will not be able to walk before the stroke will not be included in the study
If the patient can not safely use the robot due to severe spasticity (Modified ashworth scale above 3) will not be included in the study
If the patient's size does not match the robot, he will not be included in the study; The patient's pelvic circumference from the anterior superior iliac spine should be between 37 and 42 cm and also the distance between the large trochanter and the knee should be at least 25 cm.
Patient dissatisfaction to continue attending the study
Emergence of any of the factors of non-entry during the implementation of the plan in the patient

Study & Design

Study Type: interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Walking quality in the six-minute walk test. Timepoint: Measurement of distance traveled in six minutes, at the beginning of the intervention (before the intervention) and at the end of twelve sessions of treatment. Method of measurement: Six minute walk test: This test is used to assess aerobic capacity and endurance. The interval of 6 minutes is used as a result to compare changes in performance capacity. This test can be used in people of different ages and with a wide range of diagnoses. This test was initially designed to help assess patients with cardiopulmonary problems and has gradually been used in many other conditions. This test has acceptable validity and repeatability with ICC = 0.99.

Secondary Outcome Measures